Stay updated on Nab-sirolimus in Brain Cancer Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.

Latest updates to the Nab-sirolimus in Brain Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, indicating an internal update to the site. No study information or user actions are affected by this change.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows 'No longer looking for participants', indicating recruitment has closed, and adds new sections for user guidance such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The header 'Intervention / Treatment' was replaced by 'Intervention/Treatment', and the footer revision note updated to 'Revision: v3.6.0'.SummaryDifference0.4%

- Check24 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous v3.5.4, signaling a minor update to the entry’s metadata and display.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page. This change represents a backend version update and does not modify the study content or results.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now displays a newer ClinicalTrials.gov site revision identifier (v3.5.3 instead of v3.5.2), indicating a minor platform/version update rather than a change to the study record.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nab-sirolimus in Brain Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.